Access to Genomic Testing and Targeted Therapy in Advanced Non-Small Cell Lung Cancer (NSCLC): A Single-Institution Study

被引：0
|
作者：
Freile, Berenice [1 ]
Enrico, Diego [1 ]
Tsou, Florencia [1 ]
Waisberg, Federico [1 ]
Rodriguez, Andres [1 ]
Pombo, Teresa [1 ]
Mendoza, Andrea [1 ]
Salanova, Ruben [1 ]
Chacon, Matias [1 ]
Pupareli, Carmen Sofia [1 ]
Martin, Claudio [1 ]
机构：
[1] Inst Alexander Fleming, Caba, Argentina
来源：
JOURNAL OF THORACIC ONCOLOGY | 2023年 / 18卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PP.05
引用
收藏
页码：S10 / S11
页数：2
相关论文
共 50 条
  • [1] Molecular targeted therapy in the treatment of advanced stage non-small cell lung cancer (NSCLC)
    Kumarakulasinghe, Nesaretnam Barr
    van Zanwijk, Nico
    Soo, Ross A.
    [J]. RESPIROLOGY, 2015, 20 (03) : 370 - 378
  • [2] Prognostic and predictive factors in targeted therapy with erlotinib. A single-institution experience within a worldwide phase-4 trial in advanced Non-small Cell Lung Cancer (NSCLC)
    Heigener, D. F.
    Anamelechi, K.
    Probst, B.
    Reck, M.
    Nettelnbreker, E. -M.
    Gatzemeier, U.
    [J]. ONKOLOGIE, 2008, 31 : 131 - 131
  • [3] Durvalumab Outcomes in Stage III Non-small Cell Lung Cancer: A Single-institution Study
    Trinh, Jonathan Q.
    Xiong, Ying
    Smith, Lynette M.
    Abughanimeh, Omar
    Marr, Alissa S.
    Ganti, Apar K.
    [J]. ANTICANCER RESEARCH, 2024, 44 (02) : 605 - 612
  • [4] Multi-targeted therapy in recurred and advanced Non-Small Cell Lung Cancer (NSCLC) in Thailand
    Prempree, Thongbliew
    Wongpaksa, Charlorboon
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S705 - S706
  • [5] Targeted therapy in advanced non-small cell lung cancer (NSCLC): Where do we stand?
    Azim, Hatem A., Jr.
    Ganti, Apar Kishor
    [J]. CANCER TREATMENT REVIEWS, 2006, 32 (08) : 630 - 636
  • [6] Biomarkers for targeted therapy selection in non-small cell lung cancer (NSCLC)
    Paz-Ares, L.
    [J]. EUROPEAN JOURNAL OF CANCER, 2011, 47 : S4 - S4
  • [7] A Single-Institution Experience of Afatinib in Patients with EGFR-Mutated Advanced Non-Small Cell Lung Cancer
    Minemura, Hiroyuki
    Yokouchi, Hiroshi
    Hirai, Kenichiro
    Koizumi, Tatsuhiko
    Kanazawa, Kenya
    Tanino, Yoshinori
    Munakata, Mitsuru
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S1230 - S1231
  • [8] Immunotherapy as an effective therapy approach for advanced non-small cell lung cancer (NSCLC): A single institution experience in the context of clinical trials and expanded access use
    Martinez Perez, I.
    Falcon Gonzalez, A.
    Sanchez Simon, I.
    Cervera, A.
    Alonso Garcia, M.
    Flor Oncala, M. J.
    Gallego Jimenez, I.
    Maiquez, P.
    Jimenez Gonzalez-Serna, L.
    Corral, J.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2016, 11 (04) : S135 - S136
  • [9] Combination of immunotherapy with targeted therapies in advanced non-small cell lung cancer (NSCLC)
    Moya-Horno, Irene
    Viteri, Santiago
    Karachaliou, Niki
    Rosell, Rafael
    [J]. THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2018, 10
  • [10] Advanced Non-Small Cell Lung Cancer (NSCLC): Maintenance Therapy for All?
    Nooshin Hashemi-Sadraei
    Nathan A. Pennell
    [J]. Current Treatment Options in Oncology, 2012, 13 : 478 - 490
12345